These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1378062)

  • 1. Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.
    Müller F; Stiegler C; Hadding U
    J Clin Microbiol; 1992 Jun; 30(6):1544-50. PubMed ID: 1378062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W; Liu WE; Li YM; Luo S; Zhong YM
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay.
    Svennerholm AM; Wikström M; Lindblad M; Holmgren J
    J Clin Microbiol; 1986 Oct; 24(4):585-90. PubMed ID: 2429984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and characterization of monoclonal antibody against Clostridium difficile toxin A].
    Fu SW; Zhou DY; Lai ZS; Xue J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):376-8. PubMed ID: 15193243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
    Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays.
    Speirs JI; Akhtar M
    Can J Microbiol; 1991 Aug; 37(8):650-3. PubMed ID: 1954579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
    Padhye VV; Zhao T; Doyle MP
    J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.
    Lyerly DM; Phelps CJ; Toth J; Wilkins TD
    Infect Immun; 1986 Oct; 54(1):70-6. PubMed ID: 2428753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
    Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
    Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins.
    He X; Wang J; Steele J; Sun X; Nie W; Tzipori S; Feng H
    J Microbiol Methods; 2009 Jul; 78(1):97-100. PubMed ID: 19393695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.
    Genth H; Selzer J; Busch C; Dumbach J; Hofmann F; Aktories K; Just I
    Infect Immun; 2000 Mar; 68(3):1094-101. PubMed ID: 10678912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.
    Doern GV; Coughlin RT; Wu L
    J Clin Microbiol; 1992 Aug; 30(8):2042-6. PubMed ID: 1500512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.
    Gilbert J; Leslie J; Putler R; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Anaerobe; 2021 Feb; 67():102299. PubMed ID: 33227427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
    J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
    Staneck JL; Weckbach LS; Allen SD; Siders JA; Gilligan PH; Coppitt G; Kraft JA; Willis DH
    J Clin Microbiol; 1996 Nov; 34(11):2718-21. PubMed ID: 8897171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
    Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
    J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.